0001950047-23-001996.txt : 20230630 0001950047-23-001996.hdr.sgml : 20230630 20230630161819 ACCESSION NUMBER: 0001950047-23-001996 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AC Immune SA CENTRAL INDEX KEY: 0001651625 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37891 FILM NUMBER: 231061973 BUSINESS ADDRESS: STREET 1: EPFL INNOVATION PARK, BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 BUSINESS PHONE: 41 21 345 91 21 MAIL ADDRESS: STREET 1: EPFL INNOVATION PARK, BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Pfeifer Andrea CENTRAL INDEX KEY: 0001697107 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AC IMMUNE SA STREET 2: EPFL INNOVATION PARK BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 144 1 primary_doc.xml 144 0001697107 XXXXXXXX LIVE 0001651625 AC IMMUNE SA 001-37891 EPFL INNOVATION PARK Building B 1015 Lausanne V8 00000 41213459121 ANDREA PFEIFER Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

100000 308000.00 83620364 06/30/2023 NASDAQ Common 06/20/2004 Series A pref. shares Issuer N 89809 06/20/2004 Cash Common 06/20/2005 Series B pref. shares Issuer N 10191 06/20/2005 Cash Y 06/30/2023 03/31/2023 /s/ Andrea M.A. Pfeifer